Results 141 to 150 of about 540,738 (249)

OMAnnotator: a novel approach to building an annotated consensus genome sequence. [PDF]

Bioinform Adv
Bates S, Dessimoz C, Nevers Y.
europepmc   +1 more source

patches and local annotations, slide 039, zoom 248x248 um2

, 2022
Bálint Pataki, Alex Olar, Dezső Ribli, Adrián Pesti, Endre Kontsek, Benedek Gyöngyösi, Ágnes Bilecz, Tekla Kovács, Kristóf Kovács, Zsófia Kramer, András Kiss, Miklós Szócska, Péter Pollner, István Csabai   +13 more
openalex   +1 more source

Tumor mutational burden as a determinant of metastatic dissemination patterns

Molecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal, Andrea Moreno‐Manuel, Miguel Salvadó‐Pertierra, Cristina Santos‐Vivas, Rebeca Sanz‐Pamplona   +4 more
wiley   +1 more source

Full-length transcriptome of Oocystis borgei under stress condition

Frontiers in Genetics, 2023
Chengcheng Deng, Jiajia Ren, Ting Hong, Yang Liu, Feng Li, Yulei Zhang, Changling Li, Zhongdian Dong, Xianghu Huang, Ning Zhang, Ning Zhang   +10 more
doaj   +1 more source

Functional Annotation Workflow for Fungal Transcriptomes. [PDF]

J Fungi (Basel)
Morihara N, Bono H.
europepmc   +1 more source

patches and local annotations, slide 186, zoom 124x124 um2

, 2022
Bálint Pataki, Alex Olar, Dezső Ribli, Adrián Pesti, Endre Kontsek, Benedek Gyöngyösi, Ágnes Bilecz, Tekla Kovács, Kristóf Kovács, Zsófia Kramer, András Kiss, Miklós Szócska, Péter Pollner, István Csabai   +13 more
openalex   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Preliminary Exploration of Fluvastatin Inhibiting Proliferation, Migration and Invasion of Lung Cancer Cells and Reversing Paclitaxel Resistance: Mechanism Exploration Based on Multi-Omics Analysis. [PDF]

Drug Des Devel Ther
Xu H, Du Z, Shui J, Li X, Tang J, Li G.
europepmc   +1 more source

Targeting p38α in cancer: challenges, opportunities, and emerging strategies

Molecular Oncology, EarlyView.
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley   +1 more source

Assessing Impact of Data Quality in Early Post-Operative Glioblastoma Segmentation. [PDF]

J Imaging
Helland RH, Bouget D, Jakola AS, Muller S, Solheim O, Reinertsen I.   +5 more
europepmc   +1 more source